Rafferty Asset Management
DNA icon

Rafferty Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Rafferty Asset Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,091
Closed -$468K – 1180
2024
Q1 		$468K Sell
10,091
-1,183
-10% -$61.2K ﹤0.01% 991
2023
Q4 		$762K Buy
11,274
+1,482
+15% +$90.7K ﹤0.01% 866
2023
Q3 		$709K Sell
9,792
-120
-1% -$9.59K ﹤0.01% 864
2023
Q2 		$737K Buy
9,912
+223
+2% +$13.2K ﹤0.01% 893
2023
Q1 		$515K Sell
9,689
-88
-0.9% -$5.58K ﹤0.01% 930
2022
Q4 		$661K Buy
9,777
+938
+11% +$86.3K 0.01% 848
2022
Q3 		$1.1M Buy
8,839
+8,298
+1,534% +$989K 0.01% 647
2022
Q2 		$52K Buy
+541
New +$66K ﹤0.01% 1100

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return